Literature DB >> 29656657

Phytochemical profile and biological activities of Deverra tortuosa (Desf.)DC.: a desert aromatic shrub widespread in Northern Region of Saudi Arabia.

Arbi Guetat1,2, Abdennacer Boulila3, Mohamed Boussaid2.   

Abstract

The present study describes the chemical composition of the essential oil of different plant parts of Devrra tortuosa; in vivo and in vitro biological activities of plant extract and essential oils. Apiol was found to be the major component of the oil (between 65.73% and 74.41%). The best antioxidant activities were observed for the oil of flowers (IC50 = 175 μg/ml). The samples of stems and roots exhibit lower antioxidant activity (IC50 = 201 μg/ml and 182 μg/ml, respectively). The values of IC50 showed that the extracts of methanol exhibit the highest antioxidants activities (IC50 = 64.8 102 μg/ml). EOs showed excellent antifungal activity against yeasts with low azole susceptibilities (i.e. Malassezia spp. and Candida krusei). The MIC values of oils varied between 2.85 mg/mL and 27 mg/mL. The obtained results also showed that the plant extracts inhibited the germination and the shoot and root growth of Triticum æstivum seedlings.

Entities:  

Keywords:  Essential oils; Saudi Arabia; biological activities; plant extracts

Mesh:

Substances:

Year:  2018        PMID: 29656657     DOI: 10.1080/14786419.2018.1460842

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  2 in total

1.  Deverra triradiata Hochst. ex Boiss. from the Northern Region of Saudi Arabia: Essential Oil Profiling, Plant Extracts and Biological Activities.

Authors:  Arbi Guetat; Abdelrahman T Abdelwahab; Yassine Yahia; Wafa Rhimi; A Khuzaim Alzahrani; Abdennacer Boulila; Claudia Cafarchia; Mohamed Boussaid
Journal:  Plants (Basel)       Date:  2022-06-09

Review 2.  Phytomedicine from Middle Eastern Countries: An Alternative Remedy to Modern Medicine against Candida spp Infection.

Authors:  Mohammad Zubair Alam; Mohd Sajjad Ahmad Khan
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-14       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.